FAME - Sponsored by Alimera Sciences

Completed Study | Duration: 36 months

IluvienĀ® is an extended release intravitreal insert developed for the treatment of Diabetic Macular Edema. During the trial, IluvienĀ® demonstrated a significant effect on improving vision and reducing edema at week three. This effect was maintained throughout the 36 months of the trial.

Return to Diabetic Retinopathy


Loading ...

Ophthalmologist Website Design | Accessibility Policy
Washington DC FAME Study | Diabetic Macular Edema Treatment in Maryland | Virginia FAME Study